Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children

NCT00822380 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2009-01-14

No results posted yet for this study

Summary

Anemia continues to be a major public health problem in many regions of the world and it is still not clear which strategy is more effective in children population in terms of adherence and efficacy. The objective was to evaluate the efficacy and acceptance of several strategies that have been recently recommended to treat anemia on anemic children (6 to 43 mo):Iron supplement, iron+folic acid supplement, a multiple micronutrients supplement a micronutrient fortified complementary food in the form of porridge powder or zinc+iron+ascorbic acid fortified water.

Conditions

Interventions

DIETARY_SUPPLEMENT

Iron

Daily 20mg of ferrous sulfate in liquid solution during 4 months

DIETARY_SUPPLEMENT

Multiple micronutrients supplement

Daily supplement with 10mg of iron plus several micronutrients following a formula designed to treat anemia in indigenous population in Mexico. During 4 months.

DIETARY_SUPPLEMENT

micronutrient fortified porridge powder

Daily powdered complementary food designed for a national program in Mexico with 10mg of iron plus several micronutrients during 4 months

DIETARY_SUPPLEMENT

Iron and ascorbic acid fortified water

A drink water product fortified with 6.7 mg ofiron, zinc and ascorbic acid. This product was asked to be used for drinking and for cooking for the child during 4 months.

DIETARY_SUPPLEMENT

Iron plus folic acid supplement

Daily liquid solution following the daily iron (12.5mg)and folic acid recommendation of UNICEF to treat anemia during 4 months

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY
  • Universidad Autonoma de Queretaro

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
42 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2003-11-30
Completion
2004-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822380 on ClinicalTrials.gov